Pharmacogenomics is the study of genetic markers that predict a patient's reaction to hormone therapies, chemotherapy, and targeted treatments in the context of breast cancer.
Pharmacogenomics is the study of genetic markers that predict a patient's reaction to hormone therapies, chemotherapy, and targeted treatments in the context of breast cancer.
Pharmacogenomics is the study of genetic markers that predict a patient's reaction to hormone therapies, chemotherapy, and targeted treatments in the context of breast cancer.
Pharmacogenomics is the study of genetic markers that predict a patient's reaction to hormone therapies, chemotherapy, and targeted treatments in the context of breast cancer.
Personalized medicine, which modifies treatment to each cancer patient's particular genetic, biological, and personal traits, has become a game-changer in recent years
Personalized medicine, which modifies treatment to each cancer patient's particular genetic, biological, and personal traits, has become a game-changer in recent years
Genomic Profiling—also referred to as genetic testing or tumor sequencing—involves examining the DNA of the patient's healthy cells as well as the cancer cells.
Genomic Profiling—also referred to as genetic testing or tumor sequencing—involves examining the DNA of the patient's healthy cells as well as the cancer cells.